Biostatisticians from Cytel will be delivering a course on adaptive designs at this year’s International Society for Clinical Biostatistics. The course will help attendees develop strategies for interim decision-making, by providing an overview of recent advances in statistical methodology and applying them to case studies in oncology and cardiology
Members of Cytel Consulting are not only expert biostatisticians. In addition, they have practical experience designing adaptive trials for some of the leading biopharmaceutical companies in the industry. They will draw on this experience to cover topics on:
- Sample size re estimation
- Preserving Type 1 Error
- Computing Power
- Obtaining Point Estimates
- Computing Confidence Intervals
Those interested in learning about new technology for trial forecasting, prediction and dose-escalation are also welcome to use this opportunity to learn about the recently released East 6.3.
Curious about Cytel Consulting’s approach?
Designing adaptive trials?
Explore the videos below:
Adaptive Sample Size Re-Estimation in the VALOR Trial:
Adaptive 2-stage Design Supporting the Fulyzaq® Approval:
Adaptive Trials in the Exploratory Stage: